首页> 中文期刊> 《肿瘤学与转化医学(英文) 》 >伊立替康为基础的化疗方案治疗转移性结直肠癌的疗效与常见毒副反应的相关性研究(英文)

伊立替康为基础的化疗方案治疗转移性结直肠癌的疗效与常见毒副反应的相关性研究(英文)

             

摘要

Objective:The aim of our study was to investigate if common toxicities are correlated to objective response rate(ORR) in metastatic colorectal cancer(mCRC) patients treated by irinotecan based regimens.Methods:Univariate and multivariate logistic regression analyses were performed to evaluate correlations between common toxicities and binary ORR in 106 mCRC patients from a prospective cohort treated with irinotecan based regimens.Results:The most frequent severe toxicities(Grade 3/4) were as follows:neutropenia(27.4%),diarrhea(16.9%),leucopenia(12.6%),vomiting(3.2%) and thrombocytopenia(2.1%).Thrombocytosis was observed in 25(26.3%) patients.ORR was 25.3%.Thrombocytopenia(P = 0.014),line of chemotherapy(P = 0.028) and thrombocytosis(P = 0.033) were correlated with ORR in univariate analysis.In multivariate analysis,thrombocytopenia(odds ratio [OR] = 8.600,95% confidence interval [CI] = 1.705-43.385,P = 0.009) and first line chemotherapy(OR = 5.155,95% CI = 1.153-23.256,P = 0.032) positively related to ORR.Conclusion:Thrombocytopenia may be an indicator of ORR in mCRC patients treated by irinotecan plus 5-fluorouracil/capecitabine.Evidence is not strong enough to prove that irinotecan based regimens-induced diarrhea,leucopenia,neutropenia or vomiting is associated with ORR.

著录项

相似文献

  • 中文文献
  • 外文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号